In Phase 1, the team will run four different laboratory-controlled trials to map stress and performance onto physiological outcomes. State-of-the-art molecular profiling and sensor technologies will be used to define a set of molecular biomarkers derived from blood, saliva, interstitial fluid, and sweat, alongside non-molecular physiological measures. Furthermore, this phase of the project aims to develop prototype sensors for monitoring the identified markers in a parallel project.